NIHDA201800009_Amendment_01.pdf

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE

2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)

7. ADMINISTERED BY (If other than Item 6) CODE

STANDARD FORM 30 (REV. 11/2016)

Prescribed by GSA FAR (48 CFR) 53.243

FACILITY CODE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED (SEE ITEM 13)

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.

12. ACCOUNTING AND APPROPRIATION DATA (If required) copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER

NUMBER IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

15C. DATE SIGNED

15A. NAME AND TITLE OF SIGNER (Type or print)

16C. DATE SIGNED

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

PAGE OF PAGES

6. ISSUED BY CODE

8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X)

CODE

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

Previous edition unusable

KVJ

Lisa V. Bielen, Contracting Officer, NIDA

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PURPOSE: To modify Attachment 5. This amendment supersedes Attachment 5 in the original solicitation. Offerors shall provide a response to all 5 Sample Task Orders as detailed in the Solicitation. All references to the number of Sample Task Orders are revised from 4 to 5.

Proposal Due Date: 3:00 p.m. (Eastern) on August 31, 2018 (UNCHANGED)

Note: The offeror should acknowledge on the cover page or first page of its business and technical proposals receipt of the RFP and this Amendment.

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

NIDA Section, Contracts Management Branch Blue Office of Acquisition, NIDA 6001 Executive Boulevard, Room 4211, MSC 9559 Bethesda, Maryland 20892-9559

To All Potential Offerors NIHDA201800009

1 19

See Block 16C

July 18, 2018

Request for Proposal NIHDA201800009 Amendment 01

AMENDMENT 01 TO REQUEST FOR PROPOSAL (RFP) NIHDA201800009

Attachment 5, Sample Task Order 1-4, is superseded by the following. Offerors shall provide a response to all 5 sample task orders with their initial proposal. All references to the number of sample task orders throughout the Solicitation are changed from four (4) to five (5).

SAMPLE TASK ORDERS

NATIONAL INSTITUTE ON DRUG ABUSE (NIDA)

NIDA SECTION, CONTRACTS MANAGEMENT BRANCH BLUE

Solicitation Number: NIHDA201800009, Amendment 01 Title: Analytical Services Center for Medications

Development Program Date: July 26, 2018

I. Background Information

For purposes of proposal preparation, offerors are to provide separate technical proposals (including timelines) and cost estimates for each of the 5 sample Task Orders listed below. Additional information for proposal preparation is provided within the description of each study.

Technical proposals should describe the approach to be used and the deliverables proposed. Technical proposals should be detailed and specific.

Cost estimates for cost-reimbursement Task Orders should provide estimated cost and effort. At a minimum, cost estimates should include:

• TO leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

• Fringe benefits (if applicable).

• Other direct costs

• Travel

• Subcontracts

• Consultants

• Indirect costs

• Total estimated costs for this Order

• Fee, if applicable

• Total estimated costs and fee for this Order

Cost estimates for fixed price Task Orders should provide a breakdown of per unit costs, proposed fee, and total estimated price for the Task Order.

II. Sample Task Order 1

Contractor: TBD TO Title: Administrative Suport

Contract: TBD TO No: Sample Task Order 2

T.O. Originator: NIDA COR Task Areas:

TO Type: Fixed Price Completion

PART I: TASK ORDER REQUEST FOR PROPOSAL

A. Period of Performance: 12 Months from date of Task Order award

B. Task Description: The scope of this task is for services to provide general support for administration of the basic contract. This does not include the administrative activities that will be performed under each awarded task order.

a. The Contractor shall prepare and submit contract deliverables including:

i. Individual Task Reports (i.e., Methods Development and Validation Reports, Analytical Study Reports);

ii. Monthly Progress Reports (including Vulnerability Scanning Report);

iii. Annual Progress Reports;

iv. Final Contract Report w/Summary of Salient Results;

v. All data, etc. in accordance with task G;

vi. Annual Utilization reports;

vii. Final Invention Statement;

viii. Reporting of Financial Conflict of Interest (FCOI);

ix. Roster of Employees Requiring Suitability Investigations;

x. IT Security Plan, IT Risk Assessment, and FIPS 199 Assessment (including Annual

Updates);

xi. Reports of New and Departing Employees; and,

xii. Non-Disclosure Agreements.

b. The Contractor shall provide services for the general administration of the contract.

C. Task Leader: NIDA COR

D. Deliverables: As stated in Task Description (above) and Section F, Article F.2. Deliveries.

E. Proposal Instructions: See Part II, Contractor’s Response to T.O. Request. In addition, the Contractor will demonstrate its understanding of this Task Order by describing the work needed to be performed. Contractor’s response to this task order is due with initial proposals.

PART II: CONTRACTOR'S RESPONSE TO T.O. REQUEST

(The Contractor may attach additional sheets to this form to present requested data.)

A. Estimated Cost and Effort

a. List T.O. leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

b. Fringe benefits (if applicable).

c. Other direct costs

d. Travel

e. Subcontracts

f. Consultants

g. Indirect costs

h. Total estimated costs for this Order

i. Fee, if applicable

j. Total estimated costs and fee for this Order

B. Detailed description of the approach to be used and of the deliverable(s). Be specific.

APPROVAL TO PROCEED: The Contractor shall not exceed the estimated T.O. amount, or change the T.O. leader without the prior written approval of the Contracting Officer Representative and the Contracting Officer.

1. For the Contractor: _______________________________ Date:

(Signature) Typed Name

2. For the Government _______________________________ Date:

(COR)

_______________________________ Date:

(Contracting Officer)

III. Sample Task Order 2

Contractor: TBD TO Title: Quantitative assays for plasma samples

Contract: TBD TO No: Sample Task Order 2

T.O. Originator: NIDA COR Task Areas: A, B, F, and G

B. Task Description: This Task Order involves work described in Tasks A, B, F, and G of the Statement of Work.

The Contract shall conduct quantitative assays for plasma samples collected for a phase 1 clinical study to determine if there are PK of an opioid medication. The study may take 3 months to complete. This study involves work described in Task A, Task B, Task F and Task G of the Statement of Work. NIDA expects to issue a related task order with the contract award.

Offerors are to submit a budget estimate and technical proposal for the following:

a. Assay Development and Validation (Task A).

The Contractor shall develop and validate analytical methods to quantify the study medication in plasma with concentrations ranging from 0.1 to 100 ng/mL.

b. Quantitative Analyses in Biological Fluids by Mass Spectrometric Methods (Task B).

The Contractor shall quantify approximately 1920 plasma samples for the study medication plus incurred sample reanalysis.

c. Results and Database Maintenance (Task F).

The Contractor shall complete the assay within 4 weeks after receipt of the samples. The Contractor shall submit the data electronically to NIDA/DTMC and NIDA-designated data management center(s) within 5 days after the results are available and shall submit the final data within 10 working days after the data center has completed the query of the data.

d. Archival Maintenance of Records (Task G)

At the end of the task order or contract, the Contractor shall place all data, including laboratory notebooks, hard copies of raw data, and databases of assay results on all electronic media types, in secure storage for a period of up to 5 years in case a GLP audit is required by FDA in connection with an IND or NDA submission.

D. Deliverables: As stated in Task Description (above) to be performed from Tasks A, B, F, and G. Contractor’s response to this task order is due with initial proposals.

Note: Within the budget estimate, the Contractor shall also propose and itemize the costs for preparation and delivery of all deliverables required under the contract that this Task Order will generate, specifically Individual Task Reports (i.e. Methods Development and Validation Reports, Analytical Study Reports). These proposed costs should not include costs for preparation and delivery of the following deliverables: Monthly Progress Reports (Including the Vulnerability Scanning Report); Annual Progress Reports; Final Contract Report w/ Summary of Salient Results; All data, etc. in accordance with Task G; Annual Utilization Reports; Final Invention Statement; Reporting of Financial Conflict of Interest (FCOI); Roster of Employees Requiring Suitability Investigations; IT Security Plan, IT Risk Assessment, and FIPS 199 Assessment (including Annual Updates); Report of New and Departing Employees; and Non- Disclosure Agreements.

F. Evaluation Factors for Award: The Government will evaluate the Task Order proposal against the requirements of the TORFP. Specifically, technical and cost factors will be used to evaluate the proposal. To receive a Task Order award, the Contractor must demonstrate a satisfactory technical understanding of the Task Order requirement and proposed costs that are fair and reasonable. The technical factor is significantly more important than non-technical factors. The Government may conduct discussions prior to awarding a Task Order or award a Task Order without discussions. The Government reserves the right to cancel this TORFP at any time prior to Task Order award.

a. List T.O. leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

b. Fringe benefits (if applicable).

c. Other direct costs

d. Travel

e. Subcontracts

f. Consultants

g. Indirect costs

h. Total estimated costs for this Order

i. Fee, if applicable

Typed Name

2. For the Government _______________________________ Date:

(COR)

IV. Sample Task Order 3

Contractor: TBD TO Title: Qualitative and quantitative assays of abused drugs and acetazolamide

Contract: TBD TO No: Sample Task Order 3

T.O. Originator: NIDA COR Task Areas: A, B, C, E, F, and G

TO Type: Cost Reimbursement Completion

B. Task Description: This Task Order involves work described in Tasks A, B, C, E, F, and G of the

Qualitative and quantitative assays of abused drugs and acetazolamide in samples collected from a phase 2 clinical trial evaluating a study medication for treating THC addiction.

Acetazolamide will be coadministered with the study medication to assess medication compliance during the trial. The trial will be a 12-week outpatient study involving 5 clinical sites (Boston, Baltimore, Los Angeles, Denver, and Seattle) with 40 subjects per site. The trial will take approximately 2 years to complete. This study involves work described in Task A, Task B, Task C, Task E, Task F and Task G of the Statement of Work. The Contractor shall carry out all quantitative assays using validated methods.

a. Assay Development and Validation (Task A)

The Contractor shall develop and/or validate (1) a plasma assay of the study medication concentrations between 0.1 and 100 ng/mL, (2) an immunoassay method for quantifying urine delta-9 THC acid concentrations ranging between approximately 1 ng/mL to 1000 ng/mL and (3) an assay method for quantifying urine acetazolamide concentrations ranging between approximately 0.5 to 50 ng/mL.

b. Quantitative Assays of Study Medication in Plasma Samples (Task B-1)

The Contractor shall assay 1000 plasma samples for the concentration of the study medication using an LC-MS/MS method.

c. Quantitative Assays of Acetazolamide in Urine Samples (Task B-1)

The Contractor shall assay approximately 8000 urine samples for acetazolamide concentrations by LC-MS/MS methods.

d. Quantitative Assays for Delta 9-THC Acid in Urine Samples

The Contractor shall assay approximately 5000 urine samples for delta-9 THC acid concentrations by immunoassay.

e. Qualitative Screening of Urine Samples for Abused Drugs (Task C-1).

The Contractor shall screen approximately 8,000 urine specimens for the presence of abused drugs (cocaine/BE, amphetamines, opiates, benzodiazepines and cannabinoids). The Contractor shall also determine urine creatinine concentrations.

f. Supplies for Sample Collection, Storage and Shipment (Task E).

The Contractor shall purchase and supply to clinical sites all necessary sample collection, storage and shipment containers, as well as shipment cartons along with instructions for use and shipment conditions to the clinical sites as instructed by the COR. Approximately 10,000 urine collection cups (with temperature strips for urine), 16,000 urine storage bottles an 800 plasma vials will be required. Approximately 4 shipments will be made to/from each of the 5 clinical sites.

g. Results and Database Maintenance (Task F).

Contractor shall submit the data electronically to NIDA/DTMC and NIDA-designated data

h. Archival Maintenance of Records (Task G).

to be performed from Tasks : A, B, C, E, F, and G. Contractor’s response to this T.O. Request is due with initial proposals.

Note: Within the budget estimate, the Contractor shall also propose and itemize the costs for preparation and delivery of all deliverables required under the contract that this Task Order will generate, specifically Individual Task Reports (i.e. Methods Development and Validation

Reports, Analytical Study Reports). These proposed costs should not include costs for preparation and delivery of the following deliverables: Monthly Progress Reports (Including the Vulnerability Scanning Report); Annual Progress Reports; Final Contract Report w/ Summary of Salient Results; All data, etc. in accordance with Task G; Annual Utilization Reports; Final Invention Statement; Reporting of Financial Conflict of Interest (FCOI); Roster of Employees Requiring Suitability Investigations; IT Security Plan, IT Risk Assessment, and FIPS 199 Assessment (including Annual Updates); Report of New and Departing Employees; and Non- Disclosure Agreements.

F. Evaluation Factors for Award: The Government will evaluate the Task Order proposal against the requirements of the TORFP. Specifically, technical and cost factors will be used to evaluate the proposal. To receive a Task Order award, the Contractor must demonstrate a satisfactory technical understanding of the Task Order requirement and proposed costs that are fair and reasonable. The technical factor is significantly more important than non-technical factors. The Government may conduct discussions prior to awarding a Task Order or award a Task Order

a. List T.O. leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

b. Fringe benefits (if applicable).

c. Other direct costs

d. Travel

e. Subcontracts

f. Consultants

g. Indirect costs

h. Total estimated costs for this Order

i. Fee, if applicable

Typed Name

2. For the Government _______________________________ Date:

(COR)

V. Sample Task Order 4

Contractor: TBD TO Title: Qualitative and quantitative assays of abused drugs - methamphetamine addiction

Contract: TBD TO No: Sample Task Order 4

T.O. Originator: NIDA COR Task Areas: A, C, D, F, and G

B. Task Description: This Task Order involves work described in Tasks A, C, D, F, and G of the

Qualitative and/or quantitative assays of abused drugs in urine samples collected from a phase 2 clinical trial evaluating a study medication for treating methamphetamine addiction. The trial will involve 6 clinical sites (Los Angeles, Chicago, Kansas City, Baltimore, Boston, and Seattle) and 25 subjects per site. This study involves work described in Task A, Task C, Task D, Task F and Task G of the Statement of Work.

a. Assay Development and Validation (Task A).

The Contractor shall develop and/or validate an assay method for quantifying urine methamphetamine concentrations ranging from lower than 150 ng/mL to approximately 500,000 ng/mL.

b. Qualitative Screening and Quantitative Assays of Urine Samples for

Methamphetamine/Amphetamine (Task C).

The Contractor shall screen approximately 5,000 urine specimens for methamphetamine/amphetamine using an immunoassay method. The cut-off level of urine methamphetamine/amphetamine will be 300 ng/mL. It is expected that approximately 3000 samples would show positive results in the screening assay. The Contractor shall use the above validated mass spectrometric assay method for quantifying methamphetamine and amphetamine in these 3000 urine samples.

c. Acquisition and Distribution of On-site Testing Devices (Task D).

The Contractor shall acquire and distribute 400 on-site multi-panel drug testing devices (5-panel) including THC 50, Cocaine 150, Opioid/Morphine 300, Benzodiazpines 200, Methamphetamine 300 (or lower). The Contractor shall validate the performance of the product by conducting a comparison of the onsite testing device with an automated immunoassay analyzer.

d. Results and Database Maintenance (Task F).

Contractor shall submit the data electronically to NIDA/DTMC and NIDA-designated data

e. Archival Maintenance of Records (Task G).

to be performed from Tasks A, C, D, F, and G. Contractor’s response to this T.O. Request is due with initial proposals.

Note: Within the budget estimate, the Contractor shall also propose and itemize the costs for preparation and delivery of all deliverables required under the contract that this Task Order will generate, specifically Individual Task Reports (i.e. Methods Development and Validation Reports, Analytical Study Reports). These proposed costs should not include costs for preparation and delivery of the following deliverables: Monthly Progress Reports (Including the Vulnerability Scanning Report); Annual Progress Reports; Final Contract Report w/ Summary of Salient Results; All data, etc. in accordance with Task G; Annual Utilization Reports; Final Invention Statement; Reporting of Financial Conflict of Interest (FCOI); Roster of Employees Requiring Suitability Investigations; IT Security Plan, IT Risk Assessment, and FIPS 199 Assessment (including Annual Updates); Report of New and Departing Employees; and Non- Disclosure Agreements.

F. Evaluation Factors for Award: The Government will evaluate the Task Order proposal against the requirements of the TORFP. Specifically, technical and cost factors will be used to evaluate the proposal. To receive a Task Order award, the Contractor must demonstrate a satisfactory technical understanding of the Task Order requirement and proposed costs that are fair and reasonable. The technical factor is significantly more important than non-technical factors. The Government may conduct discussions prior to awarding a Task Order or award a Task Order

a. List T.O. leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

b. Fringe benefits (if applicable).

c. Other direct costs

d. Travel

e. Subcontracts

f. Consultants

g. Indirect costs

h. Total estimated costs for this Order

i. Fee, if applicable

Typed Name

2. For the Government _______________________________ Date:

(COR)

VI. Sample Task Order 5

Contractor: TBD TO Title: Analysis of Various Analytes in Human Urine Samples

Contract: TBD TO No: Sample Task Order 5

T.O. Originator: NIDA COR Task Areas: B, D, F, and G

A. Period of Performance: 18 Months from date of Task Order award

B. Task Description: This Task Order involves work described in Tasks B, D, F and G of the

The Contractor shall conduct assays using validated methods to determine the concentration of various analytes in human urine samples collected during a long term clinical study of an extended-release buprenorphine formulation to start in mid-September 2018. Approximately 3,000 urine samples will be collected from the Clinical Study in total. It is currently estimated that the clinical trial will run for 18 months. Samples will be shipped to the Contractor for analysis as they are collected from approximately 6 clinical sites distributed throughout the US.

During the beginning of the clinical trial, samples will likely be delivered every week. As the clinical trial progresses, samples will be delivered for analysis less frequently. All samples shall be assayed within 30 days of receipt and study data shall be provided to NIDA monthly. The Contractor must follow pertinent Food and Drug Administration (FDA) Good Laboratory Practices (GLP) requirements and Guidance regarding bioanalytical methods.

The Contractor shall carry out the tasks listed below.

a. Quantitative Analysis in Biological Fluids (Task B)

The Contractor shall carry out assays utilizing validated methods to determine concentrations of various analytes. For each sample, the Contractor shall conduct assays equivalent to LabCorp assays 737834 (Opiates), 737641 (Oxycodone), 700070 (Methadone), and 764160 (Fentanyl). A total of approximately 3,000 samples will be collected from the study. Samples will be delivered on a rolling basis as they are collected.

The Contractor shall complete the assays within 4 weeks of receipt and study data shall be provided to NIDA in accordance with the Task F description below.

b. Acquisition and Distribution of On-site Testing Devices (Task D).

The Contractor shall acquire and distribute to the clinical sites on-site multi-panel drug testing devices/strips including Fentanyl, THC 50, Cocaine 150, Opioid/Morphine 300, Amphetamine 1,000 (or lower), Methamphetamine 500 (or lower), Oxycodone 300, Methadone 300 and Buprenorphine 10. The quantity is not to exceed 4,000 units. The Contractor shall ensure that the testing devices/strips provided shall not expire for a period at least 1 year from the shipping date to the sites.

The test strips/devices must be approved by the FDA and Clinical Laboratory Improvement Amendments (CLIA)-waived. The Contractor shall validate the performance of these products. The Contractor shall conduct a comparison of the onsite testing strips/devices with a lab-based method using an automated immunoassay analyzer to adequately support its performance.

c. Results and Database Maintenance (Task F).

The Contractor shall complete the assay within four weeks after receipt of the samples.

The Contractor shall be responsible for reconciliation of samples and submitted data.

The Contractor shall submit the data electronically to NIDA/DTMC and NIDA designated data management centers within 5 working days after the results are available and shall submit the final data within 10 working days after the data center has completed the query of the data. The Contractor shall provide a study report as described in the contract and as directed by the COR.

d. Archival Maintenance of Records (Task G).

electronic media types, in secure storage for a period of up to 5 years in case a GLP audit is required by FDA in connection with an Investigational New Drug (IND) or New Drug Application (NDA) submission.

to be performed from Tasks A, C, D, F, and G. Contractor’s response to this T.O. Request is due with initial proposals.

Note: Within the budget estimate, the Contractor shall also propose and itemize the costs for preparation and delivery of all deliverables required under the contract that this Task Order will generate, specifically Individual Task Reports (i.e. Methods Development and Validation Reports, Analytical Study Reports). These proposed costs should not include costs for preparation and delivery of the following deliverables: Monthly Progress Reports (Including the Vulnerability Scanning Report); Annual Progress Reports; Final Contract Report w/ Summary of

Salient Results; All data, etc. in accordance with Task G; Annual Utilization Reports; Final Invention Statement; Reporting of Financial Conflict of Interest (FCOI); Roster of Employees Requiring Suitability Investigations; IT Security Plan, IT Risk Assessment, and FIPS 199 Assessment (including Annual Updates); Report of New and Departing Employees; and Non- Disclosure Agreements.

F. Evaluation Factors for Award: The Government will evaluate the Task Order proposal against the requirements of the TORFP. Specifically, technical and cost factors will be used to evaluate the proposal. To receive a Task Order award, the Contractor must demonstrate a satisfactory technical understanding of the Task Order requirement and proposed costs that are fair and reasonable. The technical factor is significantly more important than non-technical factors. The Government may conduct discussions prior to awarding a Task Order or award a Task Order

a. List T.O. leader, specific individuals to be assigned, labor category, and estimated hours and hourly rates for each.

b. Fringe benefits (if applicable).

c. Other direct costs

d. Travel

e. Subcontracts

f. Consultants

g. Indirect costs

h. Total estimated costs for this Order

i. Fee, if applicable

Typed Name

2. For the Government _______________________________ Date:

(COR)